article thumbnail

Pharma companies must adapt to keep pace with AI developments, say experts

Pharmaceutical Technology

At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.

article thumbnail

Cloud robotics labs are accelerating drug discovery and development

Pharmaceutical Technology

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development. Lab-specific industrial co-bots can carry out both complex and repetitive tasks such as liquid handling.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Valuation of Pharma Companies: 5 Key Considerations

Drug Patent Watch

"5 Key Considerations for Valuing Pharma Companies As the pharmaceutical industry continues to evolve, accurately valuing pharma companies has become increasingly complex. Patent Portfolio Strength : A strong patent portfolio can significantly impact a company's valuation.

article thumbnail

IISc researchers find picolinic acid’s broad-spectrum antiviral abilities, scouts for partners in pharma companies

AuroBlog - Aurous Healthcare Clinical Trials blog

The Institute is now looking for partners in pharma companies to pursue further clinical development of the findings. When the compound was tested […]

article thumbnail

CpHI Europe: Pharma companies fail to engage patients early in drug development  

Pharmaceutical Technology

Experts discuss how pharma companies need to consider patient centricity earlier in their development plans.

article thumbnail

The pharma company of the future

World of DTC Marketing

So far this year he has received well over $200,000 from just about every pharma company in the U.S. It’s well known that Mitch has argued against any pharma pricing reform so obviously money does buy politicians. Pharma companies have argued that they need profit to develop new drugs but that’s a canard.

article thumbnail

Thrust on R&D to develop better medicines & demand for technologies driven by AI transforming patient care

AuroBlog - Aurous Healthcare Clinical Trials blog

The pharma companies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.

Medicine 188